Healio

FDA approves neuromodulation device for adults with major depressive disorder

The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
Clinical Advisor

FDA Clears At-Home Neuromodulation Device for Major Depressive Disorder

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...
Medical Device and Diagnostic Industry (MD+DI)

How An FDA Breakthrough Device Could Transform Coronary Care

Elixir Medical's DynamX Bioadaptor restores natural artery function, reducing the risk of future cardiac events.
Investing

FDA approves first at-home neuromodulation device for depression

BURLINGTON, Mass. and JERUSALEM - BrainsWay Ltd. (NASDAQ & TASE:BWAY) announced Monday that the U.S. Food and Drug Administration has granted Premarket Approval for Neurolief’s ProlivRx system as an ...
Hosted on MSN

A dust-sized device could supercharge quantum computers

A device smaller than a grain of dust is emerging as a surprisingly powerful candidate to reshape how quantum computers are built and scaled. Instead of relying on room-filling optics and fragile lab ...
Morningstar

Landmark RESET-RA Study Published in Nature Medicine Demonstrates Durable Efficacy and Safety of the SetPoint System for Rheumatoid Arthritis

Publication of 12-month outcomes reinforces SetPoint Medical’s pioneering role in advancing neuroimmune modulation as a new treatment paradigm for rheumatoid arthritis (RA) SetPoint Medical, a company ...
IEEE

Harmonic Elimination Strategy Design and USRP Implementation for FSK-based Backscatter Communication

Abstract: Frequency shift keying (FSK) modulation can avoid the direct path interference problem in backscatter communication (BackCom). However, due to the limited number of reflection impedances of ...